YAP1::NR4A3 and YAP1::NCOA2 fusions in poroma: expanding the spectrum of molecular alterations in poroid tumors

Virchows Arch. 2024 Oct;485(4):749-753. doi: 10.1007/s00428-024-03898-2. Epub 2024 Aug 23.

Léo-Paul Secco¹, Louis Libbrecht^{1

2}, Michiel Bonny³, Charles Lepine^{4

5}, Marián Švajdler⁶, Anne Tallet⁷, Paul-Louis Chantreau⁷, Benedicte Cormier⁸, Bernard Cribier^{9

10}, Vasiliki Siozopoulou¹, Thibault Kervarrec^{11

12

13}

¹ Department of Pathology, Cliniques Universitaires Saint-Luc, B-1200, Brussels, Belgium.
² Department of Pathology, AZ Groeninge, B-1200, Kortrijk, Belgium.
³ Department of Dermatology, AZ Groeninge Kortrijk, Kortrijk, Belgium.
⁴ Department of Pathology, University Hospital of Nantes, Nantes University, Nantes, France.
⁵ Immunology and New Concepts in ImmunoTherapy (INCIT), Inserm, CNRS, UMR 1302/EMR6001, Nantes, France.
⁶ Department of Pathology, Faculty of Medicine in Plzen, Charles University, Prague, Czech Republic.
⁷ Platform of Somatic Tumour Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
⁸ IHP Groupe, Tours, France.
⁹ Clinique Dermatologique, Hôpital Civil, Hôpitaux Universitaires, Université de Strasbourg, Strasbourg, France.
¹⁰ CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.
¹¹ CARADERM, French Network of Rare Cutaneous Cancer, Lille, France. [email protected].
¹² Department of Pathology, University Hospital of Tours, 37044, Tours Cedex 09, France. [email protected].
¹³ "Biologie Des Infections À Polyomavirus" Team, UMR1282 INRAE, University of Tours, Tours, France. [email protected].

No abstract available